Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Alzheon releases positive Phase I data of ALZ-801 to treat Alzheimer’s disease By PBR Staff Writer
US-based biopharmaceutical firm Alzheon has released positive data from Phase I clinical trial of ALZ-801, a first-in-class small molecule inhibitor of amyloid formation and neurotoxicity to treat Alzheimer’s disease (AD).
Contract Research & Services > Clinical Trials > News
Biogen reports positive interim Phase Ib results of aducanumab to treat Alzheimer’s disease By PBR Staff Writer
Biogen Idec has reported positive interim results from the Phase Ib PRIME trial of aducanumab (BIIB037), is a human recombinant monoclonal antibody (mAb), in patients with prodromal or mild Alzheimer’s disease (AD).
Contract Research & Services > Clinical Trials > News Boehringer reports positive results from Phase II psoriasis trial By PBR Staff Writer
Boehringer Ingelheim has reported positive results from a Phase II trial that evaluated the efficacy and safety of the new investigational compound BI 655066 versus ustekinumab in patients with moderate-to-severe plaque psoriasis.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Boehringer reports positive results from Phase II psoriasis trial
By PBR Staff Writer
Boehringer Ingelheim has reported positive results from a Phase II trial that evaluated the efficacy and safety of the new investigational compound BI 655066 versus ustekinumab in patients with moderate-to-severe plaque psoriasis.
Contract Research & Services > Clinical Trials > News
Sharp Clinical Services - Clinical Trials Supply Chain Services
We are a leading supplier of specialist clinical supply chain services, covering drug product development and manufacturing services, complex clinical supplies packaging, clinical labelling, as well as clinical distribution services.
Contract Research & Services > Clinical Trials > Suppliers
Upcoming Events
Find out more about Sharp Clinical Services upcoming events.
Contract Research & Services > Clinical Trials > Press Releases
Stability Issues Related to Soft Gelatin Capsule Development
Stability issues are a challenge and never ending concern for formulators. The reactivity of formulations depends on many factors but it is generally recognized that labile drugs in aqueous forms are sometimes the worst cases and in this regard, this should be a true statement for the development teams which work with SGC´s.
Contract Research & Services > Clinical Trials > Press Releases
Sharp EU Organisational Announcement
We recently announced a number of changes in our Sharp Packaging US business. I am delighted to be writing to you today to advise you of a number of important changes in our European Packaging business.
Contract Research & Services > Clinical Trials > Press Releases
Sharp Clinical Services ISO certification
Sharp Clinical Services UK is proud to announce its recent ISO 9001 and ISO 13485 certification following a successful audit by BSI.
Contract Research & Services > Clinical Trials > Press Releases
Scott Forde joins as Head of Business Development at UK site
Sharp Clinical Services, part of UDG Healthcare plc, has announced that Scott Forde has joined as Head of Business Development based at the Crickhowell site in South Wales.
Contract Research & Services > Clinical Trials > Press Releases
Frank Lis joins as President of Sharp Clinical Services
Sharp Packaging Services, part of UDG Healthcare plc, has announced that Frank Lis has joined as President of Sharp Clinical Services. In this role, Frank will have global responsibility for Sharp Clinical Services, which is the specialist clinical supply chain services business unit of the Sharp Packaging Services division of UDG Healthcare plc.
Contract Research & Services > Clinical Trials > Press Releases
Sharp Clinical Services Expand Their Deblistering Capabilities
Sharp Clinical Services Ltd. has expanded its' deblistering capabilities with the purchase of a STRIPFOIL Pharma de-blister machine.
Contract Research & Services > Clinical Trials > Press Releases
AstraZeneca releases full results from PEGASUS-TIMI 54 trial of BRILINTA
By PBR Staff Writer
AstraZeneca has released complete results from a large-scale outcomes PEGASUS-TIMI 54 trial of BRILINTA (ticagrelor) tablets for the chronic secondary prevention of atherothrombotic events in patients who had experienced a heart attack one to three years prior to study enrolment.
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests